Lung Cancer Study Group

RESEARCH ACTIVITY

Develop a dynamic that allows studies in the area of thoracic tumors to be carried out at the initiative of GECP members.

Support and participate in initiatives of other groups, societies or entities for the elaboration of transversal and multidisciplinary studies in the area of thoracic tumors

Create a Scientific Award and a Grant, in the areas of academic formation, research and / or acquisition of new techniques.

SCIENTIFIC ACTIVITY

Complete and spread, either in publication or on the websites, the national guidelines for diagnostic and treatment of chest tumors.

Streamline the Journal of the Lung Cancer Study Group, evolving into a more comprehensive format that reflects the Portuguese reality, and open to all who want to participate in it.

SOCIAL AWARENESS ACTIVITY

Improve and streamline the GECP website in real time and with greater interactivity.

Establish partnerships with patient Associations

Carry out lung cancer dissemination activities in the context of prevention, combating risk factors, and alert to signs and symptoms of thoracic oncological disease and its relationship with smoking.

REVISTA GECP

GECP JOURNAL

CONGRESSOS

CONGRESSES

FOTOGALERIA

PHOTO GALLERY


PUBLICATIONS

The GECP launches a Lung Cancer Guide for patients and caregivers, with everything you should know about the disease and the treatments currently available. The more informed you are, the better you will be able to ask the right questions and participate in decisions regarding your treatment plan.
 
You can download the Guide here!

EVENTS

AUTUMN MEETING

24 de outubro


NEWS

I have lung cancer. Should I be vaccinated against the flu? – GECP and PULMONALE join to answer all your questions questions

At the beginning of each vaccination season, lung cancer patients frequently have doubts about whether it is beneficial and safe to get the flu vaccine. This year, the COVID-19 pandemic has brought even more uncertainties on this topic. For this...

read more...

TERAVOLT reveal that patients with malignant thoracic tumors have a high risk of mortality from COVID 19

The Thoracic Cancers International COVID 19 Collaboration, also known as TERAVOLT, is an international consortium that was created to understand the impact of COVID-19 on patients with thoracic malignancies. Made up of medical experts from leading institutions around the world,...

read more...

On the International Day for the Elderly, GECP addresses the challenges in the treatment of lung cancer in geriatric age

The International Day of the Elderly is celebrated annually on the 1st of October. The western population is gradually aging. It is estimated that in 2050 28% of the European population is over 65, posing multiple economic, social and also...

read more...
2000

Founded in

197

Members

10

Studies

41

Associated Centers

Don`t copy text!